GC, S., N, M., L, J., Y, Y., S, W., E, W., . . . L, R. (2014). IL-2 therapy promotes suppressive ICOS+ Treg expansion in melanoma patients. The Journal of clinical investigation, 124(1), 99. https://doi.org/10.1172/JCI46266
Chicago Style (17th ed.) CitationGC, Sim, et al. "IL-2 Therapy Promotes Suppressive ICOS+ Treg Expansion in Melanoma Patients." The Journal of Clinical Investigation 124, no. 1 (2014): 99. https://doi.org/10.1172/JCI46266.
MLA (9th ed.) CitationGC, Sim, et al. "IL-2 Therapy Promotes Suppressive ICOS+ Treg Expansion in Melanoma Patients." The Journal of Clinical Investigation, vol. 124, no. 1, 2014, p. 99, https://doi.org/10.1172/JCI46266.
Warning: These citations may not always be 100% accurate.